Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hiroshi Gomyo Naoto Takahashi Noriko Usui |
| Publication date | September 19, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |